Company Intelligence Profile

Difgen Pharmaceuticals Private Limited

Difgen Pharmaceuticals Private Limited is the Hyderabad (Telangana)-based Indian subsidiary/affiliate of DifGen Pharmaceuticals LLC (Miramar, Florida, USA), engaged in scientific research & development / pharmaceutical R&D activities.

CIN: U24230TG2022PTC162383ActiveRoC Hyderabad

Last updated 4 September 2026

AI OverviewGenerated from public records

Difgen Pharmaceuticals Private Limited, incorporated on 6 May 2022 and based in Hyderabad, Telangana, is the Indian affiliate of DifGen Pharmaceuticals LLC of Florida, USA. It is engaged in scientific research and development and pharmaceutical R&D activities and is a DPIIT-recognised startup. The parent group develops and manufactures generic and specialty pharmaceutical products. The company is active, with secured borrowings from HDFC Bank.

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about Difgen Pharmaceuticals

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Registered nameDifgen Pharmaceuticals Private Limited
CINU24230TG2022PTC162383
PANNot available in the public sources reviewed.
StatusActive
ListingNot listed — unlisted private limited company
Incorporated06 May 2022
ROCRoC Hyderabad
Sector (NIC)Sector: "Research and Development Services" / "Professional, scientific and technical activities" — NIC: Scientific research and development
Registered address5-35/189A, Survey No. 390, Prashanthi Nagar, 100 Feet Road, IE Kukatpally, Rangareddy, Kukatpally, Balanagar, Hyderabad, Telangana - 500072
Authorized capital₹1,00,00,000 (₹1 Crore)
Paid-up capital
  • ₹1,00,00,000 (₹1 Crore) per Tofler/TheCompanyCheck latest pull; note an earlier search snippet cited ₹1,00,000 paid-up — treat paid-up capital as partial/conflicting between ₹1 Crore and ₹1,00,000 across sources
  • ₹1 Crore is the figure both dedicated fetches returned and is treated as the more current figure

Business Overview

  • Difgen Pharmaceuticals Private Limited is the Hyderabad (Telangana)-based Indian subsidiary/affiliate of DifGen Pharmaceuticals LLC (Miramar, Florida, USA), engaged in scientific research & development / pharmaceutical R&D activities
  • The India entity is recognized as a DPIIT "Recognised Startup." The US parent group develops and manufactures generic and specialty pharmaceutical products (injectables, ophthalmics, topicals, transdermal patches/dissolvable films, soft gels, solid orals) and recently acquired an FDA-registered finished-dosage manufacturing facility in Florida, expanding sterile/non-sterile inhalation, ophthalmic, otic and unit-dose manufacturing
  • Approx. 92 employees reported for the India entity per EPFO data
  • Confidence: partial (group-level info from press/LinkedIn, India-entity-specific activity detail is thin)

Directors

Confirmed via Tofler (9 listed) and TheCompanyCheck (11 listed, overlapping) — union list below; DINs available only from Tofler:

NameDINRoleAppointed
Yatin Kirtanlal Desai00030719--
Punit Chunilal Thakrar00351619--
Amol Ashok Walke00664315--
Zubin Keki Gandhi00664632--
Vijay Kumar Vasireddy03262782--
Srinivasan Vedantham09534573--
Santhanakrishnan Srinivasan09789679--
Ramandeep Singh Jaj09789813--
Krishna Chandrasekaran10243796--
Valiveti Brahmaji---

GST Registrations

GSTINStatePANStatus
36AAJCD2630H1ZTTelanganaNot obtained — PAN not disclosed on Tofler, TheCompanyCheck, or Masters India GST page (all say "not disclosed/not provided")Active

Primary GSTIN: 36AAJCD2630H1ZT (Telangana, state code 36) — Legal/Trade Name: DIFGEN PHARMACEUTICALS PRIVATE LIMITED — Registration Date: 13 June 2022 — Status: Active — Taxpayer type: Regular — Nature of business: Supplier of Services, Export & Import — Principal place of business: Door No. 5-35/189-A, 100 Ft Road, Prashanthi Nagar, IE Kukatpally, Hyderabad, Medchal Malkajgiri, Telangana 500072 (source: Masters India / search aggregation). PAN embedded in GSTIN: AAJCD2630H. Home state: Telangana. Number of GSTIN registrations: only 1 confirmed (Telangana); page referenced an "Other GST Numbers" section but no additional registrations were listed. Status: confirmed for the single Telangana GSTIN; "not obtained" for any additional state registrations.

Financials

FY2025 (year ended 31 March 2025), per TheCompanyCheck (detailed) and Tofler (range/ratios) — standalone, entity level unspecified (likely standalone, India entity):

Revenue₹76.63 Crore / Tofler range ₹75-100 Crore — YoY growth 84.15%/84%
Gross Margin10.82%; Operating Margin: 25.39%; Net Profit Margin: 23.39%
ROCE35.3%; Debt-to-Equity: 48.87
EBITDA, PAT (absolute ₹), Net Worthlocked/premium on both Tofler and TheCompanyCheck — not obtained
Borrowingsgrowth of 0.39%; Total secured borrowings/open charges ₹50.95 Lakh with HDFC Bank per TheCompanyCheck (two charges: ₹26.87L registered 28 May 2024, ₹24.08L registered 25 Jul 2022) vs Tofler's earlier snapshot showing a single ₹0.2 Crore (₹20L) charge dated 25 July 2022 — treat charge amounts as partial/evolving
Assets change-2.6%

Overall: revenue figure confirmed; EBITDA/PAT/net worth not obtained (paywalled on both platforms).

In the News

  • DifGen Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data

    Revelio Labs · 2 months ago

Headlines about Difgen Pharmaceuticals Private Limited reported by third-party publications. Recur Club does not author or endorse this coverage. Last checked 9/6/2026.

Source: Google News aggregated headlines

Charges / Loans

  • Lender = HDFC Bank Limited
  • TheCompanyCheck (more recent pull) reports two open charges totaling ₹50.95 Lakh: ₹26.87 Lakh registered 28 May 2024, and ₹24.08 Lakh registered 25 Jul 2022
  • Tofler's snapshot shows one loan/charge of ₹0.2 Crore (₹20 Lakh) dated 25 July 2022 — likely an earlier/stale snapshot before the 2024 charge was added
  • Treat total open charge quantum (₹50.95L, 2 charges) as the more current/confirmed figure

Competitors

Strides Pharma Science
large-cap listed
Windlas Biotech
mid-cap listed
Akums Drugs & Pharmaceuticals
large, unlisted/pre-IPO CDMO
Themis Medicare
small-cap listed
Suven Pharma
mid-cap listed, Hyderabad-based like Difgen

Frequently Asked Questions

What does Difgen Pharmaceuticals Private Limited do?
Difgen Pharmaceuticals Private Limited is the Hyderabad (Telangana)-based Indian subsidiary/affiliate of DifGen Pharmaceuticals LLC (Miramar, Florida, USA), engaged in scientific research & development / pharmaceutical R&D activities (per TheCompanyCheck and Tofler classification).
What is the CIN of Difgen Pharmaceuticals Private Limited?
The Corporate Identification Number (CIN) of Difgen Pharmaceuticals Private Limited is U24230TG2022PTC162383.
Where is Difgen Pharmaceuticals Private Limited registered?
Difgen Pharmaceuticals Private Limited is registered with RoC Hyderabad (TheCompanyCheck says Hyderabad; Tofler says "Telangana" — minor naming variance, same RoC office; confirmed). Registered address: 5-35/189A, Survey No. 390, Prashanthi Nagar, 100 Feet Road, IE Kukatpally, Rangareddy, Kukatpally, Balanagar, Hyderabad, Telangana - 500072 (confirmed — Tofler + TheCompanyCheck + Masters India GST all agree, near-identical wording)
When was Difgen Pharmaceuticals Private Limited incorporated?
Difgen Pharmaceuticals Private Limited was incorporated on 06 May 2022 (confirmed — Tofler + TheCompanyCheck agree).

Recur Market

Which lenders fit a company like Difgen Pharmaceuticals Private Limited?

Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.

Explore on Recur Club

More from Recur Club

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.